MELANIE BANKERD: Open Payments
NPI 1013311836 · ALCOA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 17 payments from 8 companies in 2025. Trend: 2023 $259 · 2024 $732 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $101 |
| Novo Nordisk Inc | 4 | $69 |
| PFIZER INC. | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Lilly USA, LLC | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, Rybelsus, ELIQUIS, MOUNJARO, SHINGRIX, PREVNAR 20, Kerendia, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
